These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1574997

  • 1. Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomography.
    Tedroff J, Aquilonius SM, Hartvig P, Lundqvist H, Bjurling P, Långström B.
    Acta Neurol Scand; 1992 Mar; 85(3):166-73. PubMed ID: 1574997
    [Abstract] [Full Text] [Related]

  • 2. A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
    Torstenson R, Tedroff J, Hartvig P, Fasth KJ, Långström B.
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1142-9. PubMed ID: 10532639
    [Abstract] [Full Text] [Related]

  • 3. Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
    Doudet DJ, Aigner TG, McLellan CA, Cohen RM.
    Psychiatry Res; 1992 Nov; 45(3):153-68. PubMed ID: 1283014
    [Abstract] [Full Text] [Related]

  • 4. Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor response.
    Tedroff J, Aquilonius SM, Hartvig P, Bredberg E, Bjurling P, Långström B.
    Acta Neurol Scand; 1992 Feb; 85(2):95-102. PubMed ID: 1574995
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
    Kanazawa M, Ohba H, Harada N, Kakiuchi T, Muramatsu S, Tsukada H.
    J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
    [Abstract] [Full Text] [Related]

  • 6. Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography.
    Chiueh CC, Firnau G, Burns RS, Nahmias C, Chirakal R, Kopin IJ, Garnett ES.
    Adv Neurol; 1987 Feb; 45():167-9. PubMed ID: 3103385
    [No Abstract] [Full Text] [Related]

  • 7. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
    Doudet DJ, Chan GL, Holden JE, McGeer EG, Aigner TA, Wyatt RJ, Ruth TJ.
    Synapse; 1998 Jul; 29(3):225-32. PubMed ID: 9635892
    [Abstract] [Full Text] [Related]

  • 8. 6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
    Barrio JR, Huang SC, Melega WP, Yu DC, Hoffman JM, Schneider JS, Satyamurthy N, Mazziotta JC, Phelps ME.
    J Neurosci Res; 1990 Dec; 27(4):487-93. PubMed ID: 2127807
    [Abstract] [Full Text] [Related]

  • 9. A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes.
    Eberling JL, Jagust WJ, Taylor S, Bringas J, Pivirotto P, VanBrocklin HF, Bankiewicz KS.
    Brain Res; 1998 Sep 14; 805(1-2):259-62. PubMed ID: 9733979
    [Abstract] [Full Text] [Related]

  • 10. Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys.
    Hayase N, Tomiyoshi K, Watanabe K, Horikoshi S, Shibasaki T, Ohye C.
    Ann Nucl Med; 1995 Aug 14; 9(3):119-23. PubMed ID: 8534583
    [Abstract] [Full Text] [Related]

  • 11. Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomography.
    Hartvig P, Lindner KJ, Tedroff J, Bjurling P, Hörnfelt K, Långström B.
    J Neural Transm Gen Sect; 1992 Aug 14; 87(1):15-22. PubMed ID: 1536715
    [Abstract] [Full Text] [Related]

  • 12. L-DOPA modulates striatal dopaminergic function in vivo: evidence from PET investigations in nonhuman primates.
    Tedroff J, Torstenson R, Hartvig P, Lindner KJ, Watanabe Y, Bjurling P, Westerberg G, Långström B.
    Synapse; 1997 Jan 14; 25(1):56-61. PubMed ID: 8987148
    [Abstract] [Full Text] [Related]

  • 13. Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography.
    Tedroff J, Aquilonius SM, Laihinen A, Rinne U, Hartvig P, Anderson J, Lundqvist H, Haaparanta M, Solin O, Antoni G.
    Acta Neurol Scand; 1990 Jan 14; 81(1):24-30. PubMed ID: 2330812
    [Abstract] [Full Text] [Related]

  • 14. Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomography.
    Hartvig P, Agren H, Reibring L, Tedroff J, Bjurling P, Kihlberg T, Långström B.
    J Neural Transm Gen Sect; 1991 Jan 14; 86(1):25-41. PubMed ID: 1751027
    [Abstract] [Full Text] [Related]

  • 15. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T, Condé F, Grégoire MC, Frouin V, Coulon C, Fuseau C, Hinnen F, Dollé F, Hantraye P, Bottlaender M.
    J Cereb Blood Flow Metab; 2001 Jul 14; 21(7):782-92. PubMed ID: 11435790
    [Abstract] [Full Text] [Related]

  • 16. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
    Bankiewicz KS, Eberling JL, Kohutnicka M, Jagust W, Pivirotto P, Bringas J, Cunningham J, Budinger TF, Harvey-White J.
    Exp Neurol; 2000 Jul 14; 164(1):2-14. PubMed ID: 10877910
    [Abstract] [Full Text] [Related]

  • 17. Positron emission tomographic studies on aromatic L-amino acid decarboxylase activity in vivo for L-dopa and 5-hydroxy-L-tryptophan in the monkey brain.
    Hartvig P, Tedroff J, Lindner KJ, Bjurling P, Chang CW, Tsukada H, Watanabe Y, Långström B.
    J Neural Transm Gen Sect; 1993 Jul 14; 94(2):127-35. PubMed ID: 8110439
    [Abstract] [Full Text] [Related]

  • 18. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 14; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 19. Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate.
    Firnau G, Sood S, Chirakal R, Nahmias C, Garnett ES.
    J Neurochem; 1987 Apr 14; 48(4):1077-82. PubMed ID: 3102690
    [Abstract] [Full Text] [Related]

  • 20. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates.
    Subramanian T, Emerich DF, Bakay RA, Hoffman JM, Goodman MM, Shoup TM, Miller GW, Levey AI, Hubert GW, Batchelor S, Winn SR, Saydoff JA, Watts RL.
    Cell Transplant; 1997 Apr 14; 6(5):469-77. PubMed ID: 9331498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.